Literature DB >> 34464658

Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change.

Vincent Wai-Sun Wong1, Jeffrey V Lazarus2.   

Abstract

Entities:  

Keywords:  MAFLD; NAFLD; NASH; metabolic dysfunction-associated fatty liver disease; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis

Mesh：

Year:  2021        PMID： 34464658     DOI： 10.1016/j.jhep.2021.08.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  MAFLD and CKD: An Updated Narrative Review.

Authors:  Alessandro Mantovani; Rosa Lombardi; Filippo Cattazzo; Chiara Zusi; Davide Cappelli; Andrea Dalbeni
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

2.  Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort.

Authors:  Yao-Wei Zou; Qian-Hua Li; Jing-Wei Gao; Jie Pan; Jian-Da Ma; Le-Feng Chen; Jian-Zi Lin; Ying-Qian Mo; Xue-Pei Zhang; Pin-Ming Liu; Lie Dai
Journal:  Front Cardiovasc Med       Date:  2022-05-13

Review 3.  MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Authors:  Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Mohammed Eslam; Jacob George; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-11-10

4.  Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients.

Authors:  Ana Luisa Ordoñez-Vázquez; Eva Juárez-Hernández; Julia María Zuarth-Vázquez; Martha Helena Ramos-Ostos; Misael Uribe; Graciela Castro-Narro; Iván López-Méndez
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.